National HealthCare Corporation

NHC Healthcare Medical Care Facilities

National HealthCare Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 16.1% from fiscal 2024. In the quarter to June 2026, revenue grew 8.83%, EPS grew 68.6%, free cash flow fell 41.6% and total debt fell 94.5%, each against the same quarter a year earlier. Revenue growth for ten consecutive years; insiders bought in the last twelve months.

242.82 2.71 −1.10%
Market cap
$3.9B
P/E
26.9×
Fwd P/E
8.4×
Dividend yield
1.08%
F-score
7/9
Altman Z
5.02
Beneish M
−2.57
Dividend safety
74/100

National HealthCare Corporation (NHC) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, National HealthCare Corporation (NHC) trades at a P/E ratio of 26.9×. Over the past ten years it has ranged from 6.3× (September 2021) to 61.5× (April 2020); the current reading is higher than 82% of that period. That is above the Medical Care Facilities industry median of 20.6× and above the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 17.7× 8.87%
FY2024 16.2× (24.02%)
FY2023 21.4× (48.03%)
FY2022 41.2× 446.95%
FY2021 7.5× (69.07%)
FY2020 24.3× 25.53%
FY2019 19.4× (4.16%)
FY2018 20.2× 20.78%
FY2017 16.7× (25.67%)
FY2016 22.5× 21.19%

Quarterly newest first

Period P/E ratio Change
Jun 2026 23.4× 16.94%
Mar 2026 20.0× 13.28%
Dec 2025 17.7× (4.79%)
Sep 2025 18.6× 17.89%
42 more quarters

Against its own ten years

Low 6.3× High 61.5×
Ten-year median 19.8×
Current reading's percentile 80

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on NHC